Ionis Pharmaceuticals (IONS) Finished Goods (2018 - 2025)

Ionis Pharmaceuticals (IONS) posted quarterly Finished Goods of $2.1 million for Q1 2025, up 959.0% year-over-year from $200000.0 in Q1 2024, and up 667.39% quarter-over-quarter from $276000.0 in Q4 2024.

Ionis Pharmaceuticals (IONS) Finished Goods (2018 - 2025) Analysis & Trends

Ionis Pharmaceuticals' Finished Goods history runs 8 years deep, the most recent figure standing at $2.1 million for Q1 2025.

  • In Q1 2025, Finished Goods rose 959.0% year-over-year to $2.1 million; the TTM figure through Mar 2025 stood at $2.1 million (up 959.0% YoY), while the FY2024 annual figure was $276000.0, up 79.22% from the prior year.
  • Finished Goods for Q1 2025 stood at $2.1 million, up from $276000.0 in the prior quarter.
  • The five-year high for Finished Goods was $2.1 million in Q1 2025, with the low at $63000.0 in Q3 2024.
  • The 5-year median for Finished Goods is $288000.0 (2022), against an average of $563294.1.
  • The sharpest annual moves came in 2021 and 2025: Finished Goods plunged 87.02% in 2021, then soared 959.0% in 2025.
  • Ionis Pharmaceuticals' Finished Goods stood at $390000.0 in 2021, then tumbled by 57.95% to $164000.0 in 2022, then retreated by 6.1% to $154000.0 in 2023, then jumped by 79.22% to $276000.0 in 2024, then jumped by 667.39% to $2.1 million in 2025.
  • Business Quant data shows IONS's Finished Goods at $2.1 million in Q1 2025, $276000.0 in Q4 2024, and $63000.0 in Q3 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 Ionis Pharmaceuticals 9.48 Bn 7.43 Bn 265.21 Mn

Historic Data

Download Data
DateValue
Mar 31, 2025 2.12 Mn
Dec 31, 2024 276,000.00
Sep 30, 2024 63,000.00
Jun 30, 2024 486,000.00
Mar 31, 2024 200,000.00
Dec 31, 2023 154,000.00
Sep 30, 2023 176,000.00
Jun 30, 2023 196,000.00
Mar 31, 2023 218,000.00
Dec 31, 2022 164,000.00
Sep 30, 2022 288,000.00
Jun 30, 2022 309,000.00
Mar 31, 2022 466,000.00
Dec 31, 2021 390,000.00
Sep 30, 2021 607,000.00
Jun 30, 2021 1.56 Mn
Mar 31, 2021 1.91 Mn
Dec 31, 2020 3.01 Mn
Sep 30, 2020 950,000.00
Jun 30, 2020 741,000.00